<DOC>
	<DOCNO>NCT02939287</DOCNO>
	<brief_summary>The purpose study help answer follow research question : - Whether administration aprepitant contain regimen olanzapine contain regimen prevent nausea vomit good patient undergo autologous stem cell transplant melphalan chemotherapy . Both medication approve United States Food Drug Administration ( FDA ) nausea vomit . - Participants randomly assign one 2 treatment group : - Arm A : aprepitant plus standard anti-emetic regimen - Arm B : olanzapine plus standard anti-emetic regimen</brief_summary>
	<brief_title>Aprepitant Versus Olanzapine With High Dose Melphalan</brief_title>
	<detailed_description>This multi-center , randomize , non-inferiority phase 3 study conduct determine appropriate anti-emetic regimen patient receive melphalan autologous stem cell transplant ( SCT ) . Candidates trial include patient age 18-80 year hematologic malignancy receive high dose melphalan part condition regimen autologous stem cell transplant . Patients enrol 2 arm . Patients Arm A receive aprepitant contain anti-emetic regimen . Patients Arm B receive olanzapine contain anti-emetic regimen . Patients must able tolerate oral medication . Patients carefully monitor rate emesis , nausea , mucositis . Any adverse event record . Impact quality life also assess . A total 184 patient accrued arm . It anticipate accrual period last approximately 2-3 year . The primary endpoint study complete response , define emesis rescue therapy within 120 hour melphalan administration .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<mesh_term>Antiemetics</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<mesh_term>Emetics</mesh_term>
	<mesh_term>Melphalan</mesh_term>
	<criteria>Autologous transplant contain high dose melphalan part condition regimen ( single 2 day melphalan ; BEAM [ carmustine , etoposide , cytarabine , melphalan ] ) able tolerate oral medication Nausea/vomiting within 12 hour plan high dose condition chemotherapy Any antiemetic treatment within 24 hour plan high dose condition chemotherapy Pregnancy Baseline correct QT interval ( QTc ) &gt; 500 ms History seizures History central nervous system ( CNS ) disease Human immunodeficiency virus ( HIV )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>autologous</keyword>
	<keyword>myeloma</keyword>
	<keyword>transplant</keyword>
</DOC>